FDA OKs Capivasertib for Certain Advanced Breast Cancers ...Middle East

Medscape - News
The first-in-class AKT inhibitor administered with fulvestrant prolonged PFS vs fulvestrant alone in patients with PIK3CA/AKT1/PTEN-altered tumors. Medscape Medical News

Hence then, the article about fda oks capivasertib for certain advanced breast cancers was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Capivasertib for Certain Advanced Breast Cancers )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News